These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21504285)

  • 21. Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia.
    Cornet E; Tomowiak C; Tanguy-Schmidt A; Lepretre S; Dupuis J; Feugier P; Devidas A; Mariette C; Leblond V; Thiéblemont C; Validire-Charpy P; Sutton L; Gyan E; Eisenmann JC; Cony-Makhoul P; Ysebaert L; Troussard X;
    Br J Haematol; 2014 Aug; 166(3):390-400. PubMed ID: 24749839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hairy cell leukemia in young patients].
    Al'-Radi LS; Samoĭlova RS; Tikhonova LIu; Diagileva OA; Naumova IN; Kaplanskaia IB; Varlamova EIu
    Ter Arkh; 2008; 80(12):53-8. PubMed ID: 19227908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment for recurrent hairy cell leukemia].
    Al'-Radi LS; Pivnik AV; Zingerman BV; Kravchenko SK
    Ter Arkh; 2012; 84(7):4-9. PubMed ID: 23038964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hairy cell leukemia: Update on molecular profiling and therapeutic advances.
    Grever MR; Blachly JS; Andritsos LA
    Blood Rev; 2014 Sep; 28(5):197-203. PubMed ID: 25110197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-interferon in hairy cell leukemia: an initial Indian experience.
    Malhotra H; Advani SH; Gopal R; Saikia TK; Nadkarni KS; Pai VR; Nair CN
    J Assoc Physicians India; 1992 Mar; 40(3):159-61. PubMed ID: 1634479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious complications associated with hairy cell leukemia.
    Golomb HM; Hanauer SB
    J Infect Dis; 1981 May; 143(5):639-43. PubMed ID: 7240806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thirty-five years in the progress of hairy cell leukemia.
    Bouroncle BA
    Leuk Lymphoma; 1994; 14 Suppl 1():1-12. PubMed ID: 7820038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectious complications of antilymphocyte therapies in solid organ transplantation.
    Issa NC; Fishman JA
    Clin Infect Dis; 2009 Mar; 48(6):772-86. PubMed ID: 19207081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines.
    Grever M; Andritsos L; Banerji V; Barrientos JC; Bhat S; Blachly JS; Call T; Cross M; Dearden C; Demeter J; Dietrich S; Falini B; Forconi F; Gladstone DE; Gozzetti A; Iyengar S; Johnston JB; Juliusson G; Kraut E; Kreitman RJ; Lauria F; Lozanski G; Parikh SA; Park J; Polliack A; Ravandi F; Robak T; Rogers KA; Saven A; Seymour JF; Tadmor T; Tallman MS; Tam CS; Tiacci E; Troussard X; Zent C; Zenz T; Zinzani PL; Wörmann B
    Leukemia; 2021 Jul; 35(7):1864-1872. PubMed ID: 33947938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual clinical manifestations, rare sites of involvement, and the association of other disorders with hairy cell leukemia.
    Tadmor T; Polliack A
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():57-61. PubMed ID: 21599607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
    Vedantham S; Gamliel H; Golomb HM
    Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
    Kraut EH
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up studies in hairy cell leukemia.
    Grever MR; Zinzani PL
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():23-6. PubMed ID: 19814694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hairy cell leukemia--a rare type of leukemia. A retrospective study on 39 patients.
    Găman AM
    Rom J Morphol Embryol; 2013; 54(3):575-9. PubMed ID: 24068406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenectomy, interferon, and treatments of historical interest in hairy cell leukemia.
    Habermann TM
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1075-86. PubMed ID: 16990108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal complications in hairy cell leukemia: diagnosis and therapy.
    Lembersky BC; Ratain MJ; Golomb HM
    J Clin Oncol; 1988 Aug; 6(8):1280-4. PubMed ID: 3411340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic effect of interferon-alpha on hairy cell leukemia].
    Abe Y; Sakai K; Igarashi T; Ishibashi T; Shiga T; Uchida T; Kariyone S
    Rinsho Ketsueki; 1989 Apr; 30(4):535-40. PubMed ID: 2769975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.